Home   About this service   Get the news  
+32 2 743 34 03

 
UCB [BE0003739530 / UCB]

UCB Media Room: Disposals of own shares

INFORMATION REGLEMENTEE


[04/09/2020 | 20:03]
https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513=
9PTmAm2ORJ-2Fb7C-2B6ekAubGqKssw5Z6o7OQxacYx-2BlT32-2B-2B0-2FydwSDHC51iLuzJO=
evz7FogSTc15c6T-2B7nPmnbHjEcy9RmMOB5WX3lSJwf9a_xDPID0vOuylFAU8fv4e60wei4Jxq=
EGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2=
F2X9c9g1wYQxvgCyyD0QQdCnbfqalQp-2BZxNBkx-2BScBsZNBbTQTEp-2BTUcBK49Y8emShhT3=
Uw-2B-2Bh2aKerVhIWBJ7Qi2XPQUvP1nEOlcV5W2gCrJopWq8abEipoqTy1Dai3iq3lR3M1r-2B=
PTPWQmSFUEjKsDuDmaME8fyDwL3wa-2Bw-2FKqhNOU5Jdcxfugcpw2uP2ivTiJ3BD0Ay5A46cv-=
2BEPGCmCLLyjL57GeB3yaOX-2F9HzdkXaA5HZkOGc7aU9Q2SG-2B0KJfj3BQ890-3D

** Disposals of own shares
------------------------------------------------------------

Brussels (Belgium), 4 September 2020 =E2=80=93 20:00 (CEST) =E2=80=93 regul=
ated information

In accordance with article 8:6 of the Royal Decree executing the Belgian Co=
de of Companies and Associations, UCB SA/NV (=E2=80=9CUCB=E2=80=9D or the =
=E2=80=9CCompany) (Euronext Brussels: UCB) announces that, following exerci=
ses of stock options by members of its personnel, it has disposed of UCB sh=
ares OTC in view of deliveries of these shares to the relevant members of t=
he personnel, within the framework of the Long Term Incentive Program of th=
e UCB Group, as follows:
https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513=
9PTmAm2ORJ-2Fb7C-2B6ekAubGqKssw5Z6o7OQxacYx0q-2BB36o-2BWKbNF8hstZFJrFbJS0zh=
BwSYZl8sZj7gYGpOIg5qGlZI6p9AO6EKLzPoLw6E_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVW=
u7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9=
g1wYQxvgCyyD0QQdCnbfqalQp-2BZxNBkx-2BScBsZNBbTQTEp-2BTUcBK49Y8emShhT3Uw-2B-=
2Bh2aKerVhIWBJ7Qi2XPQUvP1nEOlcV5W2gCrJopWq8abAd7Vz7rFSX8q7CHDTepmq0X4tXj7kP=
IkFJwawHMs4sqQfPTxPmiK77-2BZOZrNbIWBkh5XKA7khfzZeVZsPwF9sTU5L1T0KhdXpUUKugu=
H41AJ-2B1paykVc3vh9nYiOD-2FNY3iYl4-2BXACK9tXQ8dCIs8Tg-3D
This press release is available on UCB SA/NV=E2=80=99s website via the foll=
owing link (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQ=
yQ53jATUXZJD59ZUodhGC-2FyJVE-2BjXw-2Fd0j1C70r-2FZ058zOLCiGbx-2FzvKhSzxYKNx1=
8dK5MiuQ-3D-3Db7iZ_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bS=
l0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wYQxvgCyyD0QQdCnbfqa=
lQp-2BZxNBkx-2BScBsZNBbTQTEp-2BTUcBK49Y8emShhT3Uw-2B-2Bh2aKerVhIWBJ7Qi2XPQU=
vP1nEOlcV5W2gCrJopWq8abJg77KG7M5-2Bopg3-2Br757BNwGraJBOys8SyWIEZLlrK2I7j1qf=
bt52DpLwqw5M5LLBjgnAnFBKyUQer5L4GwnGNJqj2W8OLkAC3yEdONThB787OuKSBzXjtP9zmJL=
6tlCOLZm2UC2ha6DZRpKlX45c-2FY-3D .

Investor Relations
Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0
Investor Relations, UCB
T +32.2.559.94.14 antje.witte@ucb.com

Isabelle Ghellynck,
=C2=A0Investor Relations, UCB
T+32.2.559.9588, isabelle.ghellynck@ucb.com=C2=A0

About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company =
focused on the discovery and development of innovative medicines and soluti=
ons to transform the lives of people living with severe diseases of the imm=
une system or of the central nervous system. With 7 500 people in approxima=
tely 40 countries, the company generated revenue of =E2=82=AC 4.9 billion i=
n 2019. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twit=
ter: @UCB_news
=C2=A0
GenericFile
200904 - Disposals of own shares (https://u7061146.ct.sendgrid.net/ls/click=
?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ekAubGqKssw5Z6o7OQxac=
YxGWY-2BVwEqjnV4j9DZDTaD-2F364qD5OxA0dK-2FGkGEHzvik-3D1XjB_xDPID0vOuylFAU8f=
v4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeo=
COG9ekocVj-2F2X9c9g1wYQxvgCyyD0QQdCnbfqalQp-2BZxNBkx-2BScBsZNBbTQTEp-2BTUcB=
K49Y8emShhT3Uw-2B-2Bh2aKerVhIWBJ7Qi2XPQUvP1nEOlcV5W2gCrJopWq8abNSXqbL3qlpYt=
jbnF9n56EFvu4xzG-2BKBUoipgUUJmpauCvumsGyMaeXDq7L6UBDLkCju0SeIv4LJ6BH1NmfXVy=
mI60DWMpsZeeFbnUc-2BVSKASfP4fT6Oyg5yLQx6HANTCXx71w00y7D14MsoKHr-2FrGM-3D Ge=
nericFile
200904 - Vervreemding van eigen aandelen (https://u7061146.ct.sendgrid.net/=
ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ekAubGqKssw5Z=
6o7OQxacYxuYJIazmZY9SgolHK13OSClenUHfGXYAgDpWQdT5eeUs-3D50Sn_xDPID0vOuylFAU=
8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FO=
eoCOG9ekocVj-2F2X9c9g1wYQxvgCyyD0QQdCnbfqalQp-2BZxNBkx-2BScBsZNBbTQTEp-2BTU=
cBK49Y8emShhT3Uw-2B-2Bh2aKerVhIWBJ7Qi2XPQUvP1nEOlcV5W2gCrJopWq8abI-2BtM7PiT=
zoA0zgrNFB35c4eXA5xY64W-2FoMwPfi92ejneja5xNNT6Ly62lgETwiGAMzp0KIuh9lKkJ-2BU=
I2iYiGN3IaHkVzCwV0LE8CHMw9VLOKg9gm3eaDaJRup5byCHu-2BPJRmpk9fQ0LU08p5dVhf0-3=
D GenericFile
200904 - Ali=C3=A9nation d actions propres (https://u7061146.ct.sendgrid.ne=
t/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ekAubGqKssw=
5Z6o7OQxacYxclE3TRt3NyWajr65Tqh8NrCdfzv3sWfO9b3b4Wo9Xyo-3Djl9O_xDPID0vOuylF=
AU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2=
FOeoCOG9ekocVj-2F2X9c9g1wYQxvgCyyD0QQdCnbfqalQp-2BZxNBkx-2BScBsZNBbTQTEp-2B=
TUcBK49Y8emShhT3Uw-2B-2Bh2aKerVhIWBJ7Qi2XPQUvP1nEOlcV5W2gCrJopWq8abKGCFxPl3=
LFp4n5nyosU0r3LMjvFoBa3rLIJqZFim4LXazBu79CEtNrixbfpm5UigcVZNoC4CLRhk5JwfB0H=
MHpbA3klJMbpmeHJbAqF4-2B45GtDLeR2ZSeb-2Be5KqjiNlIVOQG6DoSXTPbuAcMOGRh8k-3D =
Image
Chart 1 Sept 04 2020 (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED=
-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ekAubGqKssw5Z6o7OQxacYx0q-2BB36o-=
2BWKbNF8hstZFJrBFygA5Hfu3YBEqPXXCokwU-3DP2NX_xDPID0vOuylFAU8fv4e60wei4JxqEG=
BdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2=
X9c9g1wYQxvgCyyD0QQdCnbfqalQp-2BZxNBkx-2BScBsZNBbTQTEp-2BTUcBK49Y8emShhT3Uw=
-2B-2Bh2aKerVhIWBJ7Qi2XPQUvP1nEOlcV5W2gCrJopWq8abEr-2F1ihzYkzvRFt5I9i1vBO1K=
xyUoFUZW-2F9QNU7ODY3-2Fxyzn2G0TgKOgrtSdkr9eX3S0zs9FoKorRnDkiZv3vfG6-2BuYotf=
8t9v79feXibhe6nCoVGMRVclnohk5LQ6yY4cn7qRUyHuSUqkARVlCWNdo-3D=0D
=0D
______________________=0D
If you would rather not receive future communications from UCB SA, please g=
o to https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jAT=
UeYfdhr1xEBQnaPhR2RKx1tfe2VKDZTewv5u80JomRcXqCk-2B7XpsAPigqPK6cMt1UdQAV56Wa=
K3REA6ftU4GOeDqeYFM0-2BLeLTDho4libd5VfqsCQnzWTISXA-2FpTzuanc7EE-2FqV8QAVtp1=
n-2BZtCLvKY-3DK_pb_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bS=
l0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wYQxvgCyyD0QQdCnbfqa=
lQp-2BZxNBkx-2BScBsZNBbTQTEp-2BTUcBK49Y8emShhT3Uw-2B-2Bh2aKerVhIWBJ7Qi2XPQU=
vP1nEOlcV5W2gCrJopWq8abPros8n-2FBzLct30HXihR3iP9ME4L6fVTnKlu9dZ3TkFKyFLxKEc=
Kr7LZk35kTWe7MGfWfCgbfNXR0K66kBBfg2NpfLOsKaE3MbTHaULnYC710pV2ZKY1hRgGF4Fpto=
lhhqI3sHn3M3bQv1noTIwkPgI-3D=0D
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=